Product
AGEN1571
1 clinical trial
1 indication
Indication
Advanced Solid TumorClinical trial
A Phase 1 Study Investigating AGEN1571 as a Single Agent and in Combination With a PD-1 Inhibitor and/or Botensilimab (AGEN1181) in Patients With Advanced Solid TumorsStatus: Active (not recruiting), Estimated PCD: 2027-01-20